Hypothesis

A specific population of layer V pyramidal neurons in the anterior insular cortex that express the circadian transcription factor NPAS2 drives hypothalamic SIRT1 activity via BDNF‑dependent signaling. Age‑related decline in NPAS2‑positive insular output desynchronizes the central circadian clock, accelerates epigenetic information loss, and propagates the hallmarks of aging.

Mechanistic Rationale

The insular cortex integrates interoceptive signals and modulates autonomic outflow to the hypothalamus [7]. NPAS2, a paralog of CLOCK, couples neuronal activity to metabolic state and is known to regulate BDNF expression [5]. BDNF released from insular projections can activate TrkB receptors in the suprachiasmatic nucleus (SCN) and paraventricular hypothalamic nucleus, enhancing SIRT1 transcription and NAD+‑dependent deacetylation of BMAL1/PER2 [1]. When NPAS2‑driven BDNF signaling wanes with age, hypothalamic SIRT1 falls, leading to:

• Desynchronization of SCN‑peripheral clock coupling [4]
• Reduced NAD+ salvage, impairing SIRT1‑mediated deacetylation of chromatin modifiers [2]
• Accelerated epigenetic drift, senescence, and inflammation [6] Thus, the insular NPAS2‑BDNF axis sits upstream of the hypothalamic‑circadian‑epigenetic hierarchy described in the seed research.

Testable Predictions

1. Loss‑of‑function: Conditional knockout of NPAS2 in anterior insular layer V neurons in mice will cause premature decline in hypothalamic SIRT1, increased SCN‑peripheral phase dispersion, and a measurable advance in epigenetic age (e.g., Horvath clock) within 8 weeks.
2. Gain‑of‑function: Chemogenetic activation (hM3Dq) of NPAS2‑positive insular neurons in aged mice will restore hypothalamic SIRT1 levels, re‑synchronize circadian rhythms, and delay onset of metabolic dysfunction, senescence markers, and cognitive decline.
3. Human correlation: In vivo fMRI‑based insular activity during interoceptive tasks will inversely correlate with peripheral epigenetic age estimates from blood DNA methylation across a cohort of adults aged 30‑80.

Experimental Approach

• Generate Ai14‑Cre;NPAS2^fl/fl mice to delete NPAS2 specifically in insular layer V (validate with immunostaining).
• Monitor longitudinal circadian behavior (wheel‑running, body temperature), collect SCN and liver tissue for PER2::LUC luminescence assays, and quantify SIRT1 protein and NAD+ levels.
• Perform whole‑bisulfite sequencing on liver, muscle, and brain to assess epigenetic age acceleration.
• For activation studies, inject AAV‑hM3Dq-mCherry into the insula of aged mice, administer CNO, and repeat physiological and molecular readouts.
• In humans, acquire resting‑state fMRI and interoceptive awareness scores (heartbeat detection task) alongside blood draws for epigenetic clock analysis; use linear mixed models to test the insula‑epigenetic age relationship.

Falsifiability

If NPAS2 manipulation in the insula fails to alter hypothalamic SIRT1, circadian synchrony, or epigenetic age despite efficient transfection, the hypothesis would be refuted. Conversely, confirmation would support a unified upstream controller linking interoceptive cortex, hypothalamic neuroendocrine control, and epigenetic aging.